Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study
Published 30 September 2020 Statins, commonly used to treat hypercholesterolemia, have also been proposed as anti-cancer agents. The identification of a predictive marker is essential. The 3-hydroxy-3-methylglutaryl-coenzyme-A reductase (HMGCR), which is inhibited by statins, might serve as such a marker. Thorough antibody validation was performed for four different HMGCR antibodies. Tumor express
https://www.lupop.lu.se/article/statin-use-hmgcr-expression-and-breast-cancer-survival-malmo-diet-and-cancer-study - 2025-07-05